PRESS RELEASE published on 04/17/2023 at 18:00, 3 years ago Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
PRESS RELEASE published on 04/05/2023 at 19:30, 3 years ago Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
PRESS RELEASE published on 03/16/2023 at 18:30, 3 years 1 month ago Abivax adjusts its 2023 Financial Communication Calendar
PRESS RELEASE published on 03/13/2023 at 12:00, 3 years 1 month ago Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
PRESS RELEASE published on 02/23/2023 at 20:00, 3 years 2 months ago Abivax publishes a prospectus in the context of its capital increase
PRESS RELEASE published on 02/22/2023 at 18:05, 3 years 2 months ago Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
PRESS RELEASE published on 02/17/2023 at 08:00, 3 years 2 months ago Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
PRESS RELEASE published on 02/14/2023 at 18:00, 3 years 2 months ago Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
PRESS RELEASE published on 01/31/2023 at 18:00, 3 years 3 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 01/05/2023 at 08:00, 3 years 3 months ago Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action
Published on 05/02/2026 at 21:00, 16 hours 34 minutes ago GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 1 day 12 hours ago Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 1 day 12 hours ago CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day 13 hours ago Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day 13 hours ago Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/03/2026 at 04:45, 8 hours 49 minutes ago GWM Unveils World-Class Safety & Testing Facilities: Safety Built on Data, Not Hype
Published on 05/02/2026 at 15:35, 21 hours 59 minutes ago Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 18 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/30/2026 at 20:00, 2 days 17 hours ago AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 18 hours ago AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 18 hours ago Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 19 hours ago Minutes of the Combined General Meeting held on April 30, 2026
